4833M 15/850 (Actoplus met 850 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill imprint 4833M 15/850 has been identified as Actoplus met 850 mg / 15 mg.
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 4833M 15/850 (Actoplus met 850 mg / 15 mg)
Actoplus met
- Generic Name:
- metformin/pioglitazone
- Imprint:
-
4833M
15/850 - Strength:
- 850 mg / 15 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- 64764-0158
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5553 | Physicians Total Care Inc (repackager) |
| 35356-0130 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More resources
Actoplus met is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
